GRFSGrifols, S.A.

GRFS Stock Price, Valuation & Chart | Grifols, S.A.

Compare

$7.640+0.10 (+1.33%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - General

Overview Financials Dividends Ratios

GRFS Historical price chart

GRFS Key Stats

Market Capitalization6.46B

PE Ratio8.77

EPS0.87

Trading Volume872.36K

Today's High/Low7.75/7.57

Dividend Yield0.81

52 Week High/Low9.9/6.96

Shares Outstanding845.97M

GRFS Financial Statement

GRFS Analyst ratings

GRFS Analysis & performance metrics

GRFS Company profile

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience,…

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare,…

GRFS Management team

Name

Position

Jose Ignacio Abia BuenacheCEO

Chief Executive Officer & Director

Camille Alpi

Chief Human Resources & Talent Officer

Nuria Pascual Lapeña

Vice President of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer

David Ian Bell

Chief Corporate Affairs & Legal Officer

Enrique de la Torre

Chief Compliance Officer

Lluis Pons GomezCOO

Senior Vice President of Strategy & Chief Operating Officer Office

Vicente Blanquer Torre

Chief Quality Officer

Víctor Grifols DeuCTO

Executive Director

Name

Position

Jose Ignacio Abia BuenacheCEO

Chief Executive Officer & Director

Camille Alpi

Chief Human Resources & Talent Officer

Nuria Pascual Lapeña

Vice President of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer

David Ian Bell

Chief Corporate Affairs & Legal Officer

Enrique de la Torre

Chief Compliance Officer

Lluis Pons GomezCOO

Senior Vice President of Strategy & Chief Operating Officer Office

Vicente Blanquer Torre

Chief Quality Officer

Víctor Grifols DeuCTO

Executive Director

Management Team

Jose Ignacio Abia BuenacheCEO

Chief Executive Officer & Director

Camille Alpi

Chief Human Resources & Talent Officer

Nuria Pascual Lapeña

Vice President of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer

David Ian Bell

Chief Corporate Affairs & Legal Officer

Enrique de la Torre

Chief Compliance Officer

Lluis Pons GomezCOO

Senior Vice President of Strategy & Chief Operating Officer Office

Vicente Blanquer Torre

Chief Quality Officer

Víctor Grifols DeuCTO

Executive Director

Management

Jose Ignacio Abia BuenacheCEO

Chief Executive Officer & Director

Camille Alpi

Chief Human Resources & Talent Officer

Nuria Pascual Lapeña

Vice President of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer

David Ian Bell

Chief Corporate Affairs & Legal Officer

Enrique de la Torre

Chief Compliance Officer

Lluis Pons GomezCOO

Senior Vice President of Strategy & Chief Operating Officer Office

Vicente Blanquer Torre

Chief Quality Officer

Víctor Grifols DeuCTO

Executive Director

Total 8 executives

GRFS Frequently asked questions

What is Grifols, S.A. (GRFS) Stock Price?

Current stock price of Grifols, S.A. (GRFS) stock is $7.640. The stock price is +1.33% higher in the session. The intraday range can be seen from this page. Volume of Grifols, S.A. (GRFS) stock is 872.36K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Grifols, S.A. (GRFS) stock price going up or down today?

The stock price of Grifols, S.A. (GRFS) can change with earnings, company news, and overall market sentiment. Grifols, S.A. operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Grifols, S.A. stock expensive at its current price?

Whether Grifols, S.A. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GRFS on this page is 8.77. EPS on this page is 0.87. Compare those figures with peers and growth expectations before deciding if the current Grifols, S.A. price is justified.

How has the stock price of Grifols, S.A. (GRFS) performed historically?

Historical performance for Grifols, S.A. (GRFS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GRFS reacted to past earnings and market events.

Should I buy Grifols, S.A. (GRFS) stock, at this price?

Buying Grifols, S.A. (GRFS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.